SHWZ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SHWZ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Total Revenue Growth Rate (Future 3Y To 5Y Est) is the average growth rate of total revenue estimates over a 3-year to 5-year period.
As of today, Medicine Man Technologies's Total Revenue Growth Rate (Future 3Y To 5Y Est) is N/A.
For the Drug Manufacturers - Specialty & Generic subindustry, Medicine Man Technologies's Total Revenue Growth Rate (Future 3Y To 5Y Est), along with its competitors' market caps and Total Revenue Growth Rate (Future 3Y To 5Y Est) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Medicine Man Technologies's Total Revenue Growth Rate (Future 3Y To 5Y Est) distribution charts can be found below:
* The bar in red indicates where Medicine Man Technologies's Total Revenue Growth Rate (Future 3Y To 5Y Est) falls into.
Medicine Man Technologies (OTCPK:SHWZ) Total Revenue Growth Rate (Future 3Y To 5Y Est) Explanation
Total Revenue Growth Rate (Future 3Y To 5Y Est) is the growth rate of total revenue estimates over a 3-year to 5-year period. This data is provided directly by our trusted data vendors Refinitiv or Morningstar.
In situations where both vendors do not directly provide the growth rate data, we use the most recent annual revenue for the current year and estimated future revenue figures provided by the vendor to calculate the growth rate. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average total revenue estimates growth rate.
Thank you for viewing the detailed overview of Medicine Man Technologies's Total Revenue Growth Rate (Future 3Y To 5Y Est) provided by GuruFocus.com. Please click on the following links to see related term pages.
Christine Jones | officer: Chief Legal Officer | C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239 |
Forrest Hoffmaster | officer: CFO | C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239 |
Nirup Krishnamurthy | director, officer: President | 4880 HAVANA STREET, SUITE 201, DENVER CO 80239 |
Kathy P Vrabeck | director | 625 WESTPORT PARKWAY, GRAPEVINE TX 76051 |
Jeff Garwood | director | 55 TABBY CIRCLE, DAUFUSKIE ISLAND SC 29915 |
Pratap Chandra Mukharji | director | 4880 HAVANA STREET, SUITE 201, DENVER CO 80239 |
Salim Husan Wahdan | director | 4880 HAVANA ST., STE. 201, DENVER CO 80239 |
Paul Joseph Montalbano | director | 4880 HAVANA ST., STE. 201, DENVER CO 80239 |
Brad Stewart | director | C/O SEMPER PARATUS ACQUISITION CORP., 767 THIRD AVENUE, 38TH FLOOR, NEW YORK NY 10017 |
Justin Dye | director, 10 percent owner, officer: CEO | C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA STREET, SUITE 201, DENVER CO 80239 |
Jeffrey Alley Cozad | director, 10 percent owner | C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239 |
Crw Capital Holdings Ii, Llc | 10 percent owner | 4740 W. MOCKINGBIRD LANE, STE 195579, DALLAS TX 75209 |
Crw Capital, Llc | 10 percent owner | 4740 W. MOCKINGBIRD LANE, P.O. BOX 195579, DALLAS TX 75209 |
Crw Capital Cann Holdings, Llc | 10 percent owner | 4740 W. MOCKINGBIRD LANE, P.O. BOX 195579, DALLAS TX 75209 |
Brian Ruden | 10 percent owner | C/O 4880 HAVANA STREET, SUITE 102, DENVER CO 80239 |
From GuruFocus
By PRNewswire • 08-09-2023
By PRNewswire PRNewswire • 02-16-2023
By PRNewswire • 08-08-2023
By PRNewswire PRNewswire • 04-18-2023
By PRNewswire PRNewswire • 07-12-2022
By PRNewswire • 07-26-2023
By PRNewswire PRNewswire • 06-05-2023
By PRNewswire PRNewswire • 02-21-2023
By PRNewswire PRNewswire • 07-08-2022
By PRNewswire PRNewswire • 03-24-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.